This topic contains a solution. Click here to go to the answer

Author Question: High-relief sculpture is different from low-relief sculpture in that: A. high-relief is a ... (Read 147 times)

123654777

  • Hero Member
  • *****
  • Posts: 585
High-relief sculpture is different from low-relief sculpture in that:
 
  A. high-relief is a freestanding work that can be viewed from any angle.
  B. high-relief is installed high upon the wall of a building.
  C. high-relief projects only slightly from the background.
  D. elements of high-relief may be in the round, unattached to the background.
  E. All these answers are correct.

Question 2

The sculpture The Scraper is an idealized figure from which civilization?
 
  A. Greek
  B. Roman
  C. Indian
  D. Chinese
  E. Mesoamerican



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

billybob123

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

D
Usually the foreground elements are modeled in the round, detaching themselves from the background altogether.

Answer to Question 2

A
Greek sculptors created the human form as an ideally beautiful body governed by harmonious proportions.




123654777

  • Member
  • Posts: 585
Reply 2 on: Jun 23, 2018
Great answer, keep it coming :)


amandalm

  • Member
  • Posts: 306
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library